Skip to content
OpenCapital
Get started

Neumora Therapeutics, Inc. NMRA Q1 2026 earnings

Reported May 7, 2026 · After market close

EPS-$0.30Beat by $0.02
EPS estimate-$0.32

Next report

Aug 5, 2026 (In 1 week)
EPS estimate-$0.23

Versus estimates

Diluted EPS

Q1 2026-$0.30Beat by $0.02
Q4 2025-$0.35Miss by $0.01Q3 2025-$0.35Miss by $0.01Q2 2025-$0.33Beat by $0.05Q1 2025-$0.42Miss by $0.02Q4 2024-$0.37Beat by $0.09

Ask the moment Neumora Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Neumora Therapeutics, Inc. report Q1 2026 earnings?
Neumora Therapeutics, Inc. (NMRA) reported Q1 2026 earnings on May 7, 2026 after market close.
What were Neumora Therapeutics, Inc.'s Q1 2026 revenue and EPS?
Neumora Therapeutics, Inc. reported eps of $-0.30 for Q1 2026.
Did Neumora Therapeutics, Inc. beat estimates in Q1 2026?
EPS beat the consensus estimate of $-0.32 by $0.02.
How did Neumora Therapeutics, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 28.6% from $-0.42.
Where can I find Neumora Therapeutics, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-210310) and the 10-Q periodic report (0001193125-26-211825) directly on SEC EDGAR. The filing index links above go to sec.gov.